Iktos Appoints New AI And Drug Discovery Advisory Board
17 Oct 2024 //
GLOBENEWSWIRE
Iktos Acquires Synsight, Expanding Protein And RNA Interaction Drug Discovery
08 Jul 2024 //
GLOBENEWSWIRE
Italfarmaco Partners With Iktos On AI To Speed Drug Discovery Breakthroughs
18 Jun 2024 //
GLOBENEWSWIRE
Iktos announces the appointment of Roman Fleck as Chairman of the Board
02 May 2024 //
GLOBENEWSWIRE
Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
14 Feb 2024 //
GLOBENEWSWIRE
Iktos announces the appointment of Avirup Bose as Chief Business Officer
18 Jan 2024 //
GLOBENEWSWIRE
Iktos & Bayer Announce Collaboration to expand the use of AI
14 Dec 2023 //
GLOBENEWSWIRE
Correction: Kissei introduces Iktos AI Drug Discovery System
04 Jul 2023 //
GLOBENEWSWIRE
Kissei introduces Iktos AI Drug Discovery System
03 Jul 2023 //
GLOBENEWSWIRE
Iktos and Curreio Announce Collaboration Agreement in New Drug Discovery
08 Jun 2023 //
BUSINESSWIRE
Iktos raises € 15.5m Series A round to expand its drug discovery solutions
09 Mar 2023 //
PR NEWSWIRE
Iktos Partners with Medicines for Malaria Venture in Drug Discovery
23 Nov 2022 //
BUSINESSWIRE
Iktos Announces Collaboration With Galapagos in AI For Drug Design
28 Jun 2022 //
BUSINESSWIRE
Iktos and Zealand Pharma to Develop AI Technology for Peptide Drug Design
21 Jun 2022 //
BUSINESSWIRE
Iktos, Teijin Pharma to Co-Develop New Technology for SMD Discovery
05 Apr 2022 //
BUSINESSWIRE
Iktos Collaborates With Ono in AI for New Drug Design
30 Mar 2022 //
BUSINESSWIRE
Iktos Announce Collaboration with UCB in AI for Retrosynthesis
25 May 2021 //
BUSINESSWIRE
Iktos and Facio Therapies Announce Collaboration to Use AI for FSHD Drug Design
10 May 2021 //
BUSINESSWIRE
Iktos Announces Collaboration With Pfizer in AI for Drug Design
01 Mar 2021 //
BUSINESSWIRE
Iktos Announces Additional Collaboration With Merck KGaA
05 Nov 2020 //
BUSINESSWIRE